Experiential learning influences residents knowledge about hormone replacement therapy

Teaching and Learning in Medicine

Volumn 16, Issue 3, 2004, Pages 240-246

  Hess, Rachel ^a,b,c   Chang, Chung Chou Joyce ^a   Conigliaro, Joseph ^a,b   Elnicki, D Michael ^a   McNeil, Melissa ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEMOGRAPHY; FEMALE; HEALTH SERVICE; HORMONE SUBSTITUTION; HUMAN; LEARNING; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION; POSTMENOPAUSE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RESIDENCY EDUCATION; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 4944233807     PISSN: 10401334     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15328015tlm1603_3     Document Type: Review

References (20)

1. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Annals of Internal Medicine 2000;133:933-41.
2. Scuteri A, Bos AJ, Brant LJ, Talbot L, Lakatta EG, Fleg JL. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Annals of Internal Medicine 2001;135:229-38.
3. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. Journal of the American Medical Association 1995;273:199-208.
4. Davidson MH, Maki KC, Marx P, et al. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Archives of Internal Medicine 2000;160:3315-25.
5. Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI. Journal of the American Medical Association 1996;276:1389-96.
6. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2002;288:321-33.
7. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997;350:1047-59.
8. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Annals of Internal Medicine 2000;132:689-96.
9. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 1998;280:605-13.
10. Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. A prospective, observational study. Annals of Internal Medicine 2001;135:1-8.
11. Cantor JC, Baker LC, Hughes RG. Preparedness for practice. Young physicians' views of their professional education. Journal of the American Medical Association 1993;270:1035-40.
12. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Annals of Internal Medicine 1995;122:9-16.
13. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: A meta-analysis of randomized trials. Journal of the American Medical Association 2001;285:2891-7.
14. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. Journal of the American Medical Association 2000;283:485-91.
15. McNagny SE. Prescribing hormone replacement therapy for menopausal symptoms. Annals of Internal Medicine 1999;131:605-16.
16. Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 2001; 135:939-53.
17. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. New England Journal of Medicine 2000; 343:522-9.
18. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. New England Journal of Medicine 2001;345:1243-9.
19. Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association, Circulation 2001;104:499-503.
20. Accreditation Council for Graduate Medical Education, Program requirements for residency education in internal medicine 2003;1-21. Found at http://www.acgme.org/RRC/Int_req.asp